Form4insider filings, from the source

SEC Form 4 · accession 0000904454-15-000037

GENOCEA BIOSCIENCES, INC. · GNCA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jessica Baker Flechtner
Officer — Sr. VP of Research
Period of report
Jan 29, 2015
Accepted (ET)
Feb 2, 2015 · 7:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jan 29, 2015M1,614$2.38A3,495D
Common StockJan 29, 2015S1,614$8.50D1,881D
Common StockFeb 2, 2015M1,614$2.38A3,495D
Common StockFeb 2, 2015S1,614$8.50D1,881D
Common StockFeb 2, 2015M1,471$2.38A3,352D
Common StockFeb 2, 2015S1,471$8.50D1,881D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3$2.38Jan 29, 2015M1,614D—Jun 29, 2019Common Stock1,6141,614D
Stock Option (Right to Buy)F3$2.38Feb 2, 2015M1,614D—Jun 29, 2019Common Stock1,6140D
Stock Option (Right to Buy)F4$2.38Feb 2, 2015M1,471D—Jun 29, 2019Common Stock1,4711,470D

Explanation of responses